Radiation recall dermatitis in a patient affected with pheochromocytoma after treatment with lanreotide [13]

British Journal of Dermatology

Volumn 157, Issue 5, 2007, Pages 1061-1063

  Bauza A ^a   Del Pozo, L J ^a   Escalas, J ^a   Mestre, F ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Drug reaction; Lanreotide; Pheochromocytoma; Radiotherapy; Recall dermatitis

Indexed keywords

ANGIOPEPTIN; STEROID;

ADULT; BONE METASTASIS; CASE REPORT; HUMAN; HYPERKERATOSIS; LETTER; LUNG METASTASIS; MALE; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DERMATITIS; SKIN INFILTRATE;

ADRENAL GLAND NEOPLASMS; ADULT; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; DRUG ERUPTIONS; HUMANS; LUNG NEOPLASMS; MALE; PEPTIDES, CYCLIC; PHEOCHROMOCYTOMA; RADIODERMATITIS; SOMATOSTATIN;

EID: 35348839782     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08173.x     Document Type: Letter

References (7)

1. Colao A, Dorato M, Pulcrano F et al. Gli analoghi della somatostatina nell'inquadramento clinico della patología ipofisaria. Minerva Endocrinol 2001 26:181 91.
2. Azria D, Magné N, Zouhair A et al. Radiation recall: a well recognized but neglected phenomenon. Cancer Treat Rev 2005 31:555 70.
3. Hureaux J, Le Guen Y, Tuchais C et al. Radiation recall dermatitis with pemetrexed. Lung Cancer 2005 50:255 8.
4. Ristic B. Radiation recall dermatitis. Int J Dermatol 2004 43:627 31.
5. Rosen G, Tefft M, Martinez A et al. Combination chemotherapy and radiation therapy in the treatment of metastatic osteogenic sarcoma. Cancer 1975 35:622 30.
6. Yeo W, Johnson PJ. Radiation-recall skin disorders associated with the use of antineoplastic drugs. Pathogenesis, prevalence and management. Am J Clin Dermatol 2000 1:113 16.
7. Smith K, Germain M, Skelton H. Histopathological features seen with radiation recall or enhancement eruptions. J Cutan Med Surg 2002 6:535 40.